The predictive value of EGF A61G gene polymorphism in third-line treatment with cetuximab and irinotecan of patients with metastatic colorectal cancer

Karen-Lise Garm Spindler; Anders Jakobsen

The predictive value of EGF A61G gene polymorphism in third-line treatment with cetuximab and irinotecan of patients with metastatic colorectal cancer

Karen-Lise Garm Spindler, Anders Jakobsen

Det Sundhedsvidenskabelige Fakultet

Publikation: Konferencebidrag uden forlag/tidsskrift › Poster › Forskning

Originalsprog	Engelsk
Publikationsdato	2008
Status	Udgivet - 2008
Begivenhed	DSKO's Årsmøde - Vejle, Danmark Varighed: 10. apr. 2008 → 10. apr. 2008

Konference

Konference	DSKO's Årsmøde
Land	Danmark
By	Vejle
Periode	10/04/2008 → 10/04/2008

Citationsformater

@conference{7d608670437711dd9fbe000ea68e967b,

title = "The predictive value of EGF A61G gene polymorphism in third-line treatment with cetuximab and irinotecan of patients with metastatic colorectal cancer",

author = "Spindler, {Karen-Lise Garm} and Anders Jakobsen",

year = "2008",

language = "English",

note = "null ; Conference date: 10-04-2008 Through 10-04-2008",

}